Haematopoietic stem cell (HSC) homeostasis is tightly controlled by growth factors, signalling molecules and transcription factors. Definitive HSCs derived during embryogenesis in the aortagonad-mesonephros region subsequently colonize fetal and adult haematopoietic organs 1,2 . To identify new modulators of HSC formation and homeostasis, a panel of biologically active compounds was screened for effects on stem cell induction in the zebrafish aorta-gonad-mesonephros region. Here, we show that chemicals that enhance prostaglandin (PG) E2 synthesis increased HSC numbers, and those that block prostaglandin synthesis decreased stem cell numbers. The cyclooxygenases responsible for PGE2 synthesis were required for HSC formation. A stable derivative of PGE2 improved kidney marrow recovery following irradiation injury in the adult zebrafish. In murine embryonic stem cell differentiation assays, PGE2 caused amplification of multipotent progenitors. Furthermore, ex vivo exposure to stabilized PGE2 enhanced spleen colony forming units at day 12 post transplant and increased the frequency of long-term repopulating HSCs present in murine bone marrow after limiting dilution competitive transplantation. The conserved role for PGE2 in the regulation of vertebrate HSC homeostasis indicates that modulation of the prostaglandin pathway may facilitate expansion of HSC number for therapeutic purposes.
Haematopoietic stem cell (HSC) homeostasis is tightly controlled by growth factors, signalling molecules and transcription factors. Definitive HSCs derived during embryogenesis in the aortagonad-mesonephros region subsequently colonize fetal and adult haematopoietic organs 1, 2 . To identify new modulators of HSC formation and homeostasis, a panel of biologically active compounds was screened for effects on stem cell induction in the zebrafish aorta-gonad-mesonephros region. Here, we show that chemicals that enhance prostaglandin (PG) E2 synthesis increased HSC numbers, and those that block prostaglandin synthesis decreased stem cell numbers. The cyclooxygenases responsible for PGE2 synthesis were required for HSC formation. A stable derivative of PGE2 improved kidney marrow recovery following irradiation injury in the adult zebrafish. In murine embryonic stem cell differentiation assays, PGE2 caused amplification of multipotent progenitors. Furthermore, ex vivo exposure to stabilized PGE2 enhanced spleen colony forming units at day 12 post transplant and increased the frequency of long-term repopulating HSCs present in murine bone marrow after limiting dilution competitive transplantation. The conserved role for PGE2 in the regulation of vertebrate HSC homeostasis indicates that modulation of the prostaglandin pathway may facilitate expansion of HSC number for therapeutic purposes.
A chemical genetic screen was conducted to identify new pathways modulating definitive HSC formation during zebrafish embryogenesis. runx1 and cmyb, required for mammalian HSC development, are expressed in the ventral wall of the dorsal aorta in a region analogous to the mammalian aorta-gonad-mesonephros (AGM) at 36 h post fertilization (h.p.f.) [3] [4] [5] . Wild-type embryos, incubated with individual chemicals, were examined for alterations in runx1
HSCs by in situ hybridization expression at 36 h.p.f. A high percentage of compounds (91.7%, 2,275 of 2,357) failed to alter HSC expression, whereas 35 (1.4%) and 47 (1.9%) led to increased or decreased numbers of HSCs, respectively. Among these substances, 10 affected the prostaglandin pathway (Supplementary Table 1 ). runx1
HSCs comprise a line of flattened endothelial cells (arrow) and haematopoietic clusters (arrowhead) in the aorta (Fig. 1a-c) ; linoleic acid increased HSC numbers (22 altered out of 30 scored), whereas celecoxib, a cyclooxygenase (Cox)2 inhibitor, decreased HSCs (26/ 31). PGE2 is the main effector prostanoid produced in the zebrafish 6 and is regulated by both Cox1 (also known as Ptgs1) and Cox2 (also known as Ptgs2a). Treatment of zebrafish embryos with PGE2 increased expression of runx1/cmyb (25/49), whereas Cox inhibition with SC560 (Cox1) and NS398 (Cox2) ( Supplementary Fig. 1a -e) decreased HSC numbers in 30/36 and 35/44 cases, respectively. These findings argue persuasively for a specific role of PGE2 in the formation of AGM HSCs.
Cox1 is required for the development of the aorta-vein endothelial boundary during zebrafish development 7 ; thus, alteration in Cox1 activity could have an impact on endothelial-derived HSCs. By in situ hybridization, cox2 was diffusely expressed in the tail region at 36 h.p.f. (Supplementary Fig. 1f, g ). In FACS-isolated blood and endothelial cell populations, both cox1 and cox2 were found to be highly expressed during the onset of definitive haematopoiesis. cox1 was detected in both Lmo2
1 endothelial cells and in Cd41 1 HSCs, whereas cox2 was only found in HSCs ( Supplementary Fig. 1h ). This suggests that Cox1 and Cox2 participate in HSC induction through regulation of the stem cell niche and the HSC itself.
A long-acting derivative of PGE2, 16,16-dimethyl-PGE2 (dmPGE2) caused an increase in runx1
1

/cmyb
1 AGM HSCs in 78% of embryos (97/124) (Fig. 1e, h ), whereas HSCs were inhibited by indomethacin (10 mM) treatment in 90% of embryos (92/102) ( Fig. 1k and Supplementary Fig. 1j-r) . Mass spectrometry of 36 h.p.f. embryos demonstrated that indomethacin treatment depressed PGE2 formation below detectable levels (from 1866 pg per 50 embryos to ,2 pg per 50 embryos; n 5 3) 6 . dmPGE2 had minimal effects on the vasculature, as shown by flk1 staining (Fig. 1f, i ) whereas indomethacin slightly altered the intersomitic vessels in 30% (15/49) of embryos ( Fig. 1l) . At 36 h.p.f., live bigenic cmyb-gfp; lmo2-dsRed (green-fluorescentprotein-labelled HSCs and progenitors; red-labelled HSCs and endothelium) embryos imaged by confocal microscopy exhibited significantly decreased numbers of HSCs (yellow) following indomethacin treatment, and significantly increased HSCs after dmPGE2 exposure (Fig. 1g , j, m and Supplementary Fig. 1i ). Quantitative PCR confirmed an enhancement in runx1 and cmyb expression by dmPGE2, whereas indomethacin significantly reduced the expression of each gene (Fig. 1d) .
To confirm the requirement of PGE2 activity, we used morpholino oligonucleotides to knock down expression of Cox1 and Cox2; a low dose (40 mM) inhibition of Cox1 minimizes toxicity, while mimicking Cox-dependent developmental defects 6 . Morpholino oligonucleotide knockdown of Cox1/Cox2 decreased the levels of prostaglandins and inhibited AGM HSCs (Cox1, 54/74; Cox2, 60/71) ( Supplementary Fig. 1s-u) . The morpholino-mediated effects on HSCs were reversed by dmPGE2 (Cox1 1 dmPGE2, 29/52 rescued; Cox2 1 dmPGE2, 43/60) ( Supplementary Fig. 1y, z, a' ). dmPGE2 rescued (25/45) morpholino-mediated knockdown of PGE2 synthase (35/50) indicating that PGE2 signalling was sufficient to modulate HSC formation ( Supplementary Fig. 1u, b' ). PGE2 signals through receptors Ptger1l-Ptger4l (ref. 8) . Morpholino-mediated knockdown of Ptger2l and Ptger4l diminished runx1/cmyb expression (Ptger2l, 39/63; Ptger4l, 44/67) and was not reversed by dmPGE2 ( Supplementary Fig. 1s , t, c', d'). Quantitative PCR analysis showed ptger2l/ptger4l are present in HSCs ( Supplementary Fig. 1e') . These experiments confirm that PGE2-mediated signalling regulates the formation of HSCs in the AGM region.
To examine the role of PGE2 in HSC homeostasis in adult zebrafish, we performed a kidney marrow irradiation-recovery assay in sublethally irradiated wild-type fish 9 ( Fig. 2a) . The rate of kidney marrow repopulation was significantly enhanced after exposure to 50 mM dmPGE2 (Fig. 2a, b) , with progenitor recovery preceding reconstitution of the myeloid and lymphoid populations.
Significant upregulation of stem, progenitor and endothelial cell markers was found after dmPGE2 treatment ( Supplementary Fig.  2a ). Inhibition of Cox activity significantly decreased kidney marrow recovery and affected overall survival ( Supplementary Fig. 2b ). Our results indicate that PGE2 has an important role in kidney marrow homeostasis.
We then evaluated the effects of PGE2 on murine HSC and progenitor populations. Addition of dmPGE2 to embryonic stem cells during embryoid body expansion increased haematopoietic colonies on an OP9 stromal cell layer and in methylcellulose assays 10 ( Fig. 3a,  b) . OP9, definitive erythroid and granulocyte/monocyte colonies increased in a dose-dependent manner after exposure to 10 mM (granulocyte/monocyte, P 5 0.005) and 20 mM (OP9, P 5 0.047; definitive erythroid, P 5 0.04; granulocyte/monocyte, P 5 0.007) dmPGE2. The number of multipotent granulocyte/erythrocyte/ monocyte/macrophage colonies was enhanced 2.9-fold following dmPGE2 treatment (10 mM, P 5 0.017; 20 mM, P 5 0.016). Cox1 (also known as Ptgs1), Cox2 (also known as Ptgs2), PGE2 synthase (Ptges) and Ptger1-Ptger4 were present in embryonic stem cells at all stages examined (Supplementary Fig. 3a) . Indomethacin inhibited colony growth at 20 mM (OP9, P 5 0.069) and 100 mM (granulocyte/ monocyte, P 5 0.024) (Fig. 3a, b ) and could be rescued by dmPGE2 ( Supplementary Fig. 3b, c) . These data suggest the role of PGE2 in regulating haematopoiesis is conserved between zebrafish and mammals.
To explore effects in an intact mammalian model, murine whole bone marrow (WBM) was exposed ex vivo to dmPGE2 (1 mM per 10 6 cells) and irradiated recipients were transplanted with 6 3 10 4 treated WBM cells. The number of spleen colony-forming units at day 12 post transplant (CFU-S12) was increased threefold (P , 0.0001) in recipients of dmPGE2-treated WBM (Fig. 4b, Supplementary Fig. 4b , Supplementary Table 6 ); numbers of more mature CFU-S8 colonies were also enhanced (Fig. 4a, Supplementary Fig. 3a , Supplementary Table 5 ). To assess the endogenous PGE2 requirement, WBM cells were incubated with indomethacin (1 mM 10 26 cells) or specific COX1 and COX2 inhibitors. After transplantation of 1 3 10 5 cells, a significant decrease (P 5 0.0001) in the number of CFU-S12 was observed ( Fig. 4c; Supplementary Fig. 4c , k, l; Supplementary Table  6 ). These results suggest that PGE2 enhances haematopoietic progenitor formation, and is required for CFU-S activity.
The prostaglandin pathway components are present in both stromal cell and HSC populations in mice and humans 11, 12 . Cox1, Cox2, PGE2-synthase, Ptger2 and Ptger4 are present in fetal liver HSCs and in bone marrow HSCs after 5-fluorouracil (5-FU) injury, suggesting PGE2 signalling functions in murine HSCs 13 . To determine if the increase in CFU-S number is due to a direct effect of PGE2 on the stem/progenitor cell population, FACS-isolated cKit
Lineage
2 (KSL) bone marrow cells were exposed to dmPGE2 and transplanted into irradiated recipients. Both splenic weight (Supplementary Fig. 4d ) and CFU-S12 were significantly increased, indicating that dmPGE2 can lead to cell-autonomous activation of HSCs and immature progenitors (Fig. 4d, Supplementary Table 6) .
A limiting dilution competitive repopulation analysis was conducted to determine the effects of dmPGE2 on HSC reconstitution 14 . WBM (CD45.1) exposed to dmPGE2 ex vivo was mixed independently at varying doses with a fixed number of untreated competitor cells (CD45.1/CD45.2) and injected into congenic recipient mice (CD45.2). Peripheral blood obtained at 6, 12 and 24 weeks post transplantation was examined by FACS to determine percentage test-cell contribution to haematopoietic repopulation (Supplementary Fig. 4e-j) ; positive reconstitution was defined as test-cell multilineage chimaerism .5% ( Supplementary Fig. 4f, h, i) . A significant increase in the number of repopulating cells as determined by Poisson statistics was seen in dmPGE2-treated bone marrow (Fig.  4e, Supplementary Fig. 4g, j) . At 6 weeks, the calculated frequency of engrafting cells per 10 6 WBM cells was enhanced 3.3-fold (P 5 0.005) in dmPGE2-treated WBM recipients, and the frequency of Table 2 ). e-m, dmPGE2 and indomethacin exert opposing effects on runx1/cmyb expression by in situ hybridization (e, h, k); flk1 is used to assess the effects on vascular development (f, i, l). Confocal microscopy images of cmyb-gfp; lmo2-dsRed bigenic fish exposed to dmPGE2 and indomethacin showing an increase and decrease in HSC (yellow) number along the ventral wall (yellow arrowhead) of the aorta, respectively (g, j, m). Quantitative analysis of 10 embryos in each treatment group revealed significant differences in HSC numbers ( Supplementary Fig. 1i ).
short-term repopulating HSCs was 4.0-fold (P 5 0.002) higher at 12-weeks post-transplantation (Fig. 4e, f, Supplementary Fig. 4g ). At 24 weeks, the frequency of long-term repopulating HSCs was 2.3-fold enhanced (P 5 0.05) in recipients of dmPGE2-treated cells ( Fig. 4f ; Supplementary Fig. 4j ). dmPGE2 treatment increased the frequency of repopulating HSCs in the mouse, but did not impair the differentiative capacity as seen by multilineage analysis. To determine whether dmPGE2 treatment enhanced homing to the bone marrow niche, WBM was labelled with a vital dye, CDFA, before transplantation; no significant difference in homing could be detected (P 5 0.83) ( Supplementary Fig. 5 ).
Here we have demonstrated that PGE2 enhances the number of HSCs and multipotent progenitors in two vertebrate species, zebrafish and mice. Prior studies have documented that unmodified PGE2 impairs blood-cell maturation in the mouse 15, 16 and cell cycle stimulation in CFU-S8 progenitors 17 ; however, the effects of prostaglandinmediated cell signalling on HSCs have not been examined previously. Cox1 and Cox2 seem to have distinct functions in AGM HSC formation: Cox1 is important in the formation of the haematopoietic niche, whereas Cox2 is probably involved in self-renewal and proliferation of HSCs themselves. Conversely, homozygous Cox1 or Cox2 knockout mice are viable, without apparent defects in HSC formation 18 , due to Supplementary Table 4) . a, Effect of increasing doses of dmPGE2 and inhibition of cyclooxygenase activity by indomethacin on haematopoietic differentiation in methylcellulose; numbers of definitive erythroid (E), mixed granulocyte/monocyte (GM), and multi-potent (GEMM) progenitor colonies are shown (10 mM dmPGE2: GM, P 5 0.005; GEMM, P 5 0.017; 20 mM dmPGE2: E, P 5 0.04; GM, P 5 0.007; GEMM, P 5 0.016; 100 mM indomethacin: GM, P 5 0.024). b, Effect of dmPGE2 and indomethacin on OP9 haematopoietic colony number (20 mM dmPGE2, P 5 0.047). LETTERS maternal and sibling PGE2 contribution 7, 19 . Analyses of Cox2 2/2 mice demonstrated alterations in haematocrit levels and an impaired recovery from 5-FU-induced bone marrow injury 20 ; these findings imply HSC defects in adult Cox2 2/2 mice that are compatible with our proposed role for prostaglandin in HSC homeostasis. To clarify the roles of COX1 and COX2 in regulating HSC homeostasis, we performed CFU-S12 (Fig. 4k, l) and 5-FU bone marrow recovery assays using selective inhibitors of COX1 (SC560) or COX2 (NS398). Inhibition of either enzyme significantly diminished CFU-S activity, as well as the recovery of peripheral blood and bone marrow WBC numbers ( Supplementary Fig. 4m, n) . Administration of dmPGE2 following 5-FU treatment significantly enhanced bone marrow recovery. These data suggest that both COX1 and COX2 have a role in regulating HSC homeostasis in adult mice, as in the zebrafish, and that PGE2 is the mediator of this HSC regulation. The precise mechanism of PGE2 modulation of vertebrate HSC homeostasis remains to be elucidated.
Patients undergoing bone marrow transplantation show increased endogenous PGE2 levels 21 . Our studies raise the possibility that administration of COX inhibitors following human bone marrow transplantation might impair HSC engraftment and result in delayed recovery of the WBC counts, in addition to adversely affecting platelet function. PGE2 and its analogues are safely administered to patients 22, 23 . The concentration of dmPGE2 used to expand the number of murine HSCs falls within the physiological range of PGE2 in human serum 24 , thus dmPGE2 or its derivatives may be useful for ex vivo or in vivo expansion of HSCs. Our studies illustrate that PGE2 functions as a potent regulator of HSCs in vertebrates, and may prove useful in treating patients with bone marrow failure or following transplantation.
METHODS SUMMARY
Wild-type age-matched embryos were exposed to individual test compounds from 3-somites until 36 h.p.f. and effects on HSCs were evaluated by in situ hybridization for runx1 and cmyb. Treatment with PGE2, dmPGE2 and Cox inhibitors (indomethacin, SC560, NS398) at 10 mM was used to confirm and quantify the effects of prostaglandin signalling on HSCs by in situ hybridization, quantitative PCR 9 and confocal microscopy 25 . Expression of prostaglandin pathway components in HSCs was characterized by microarray analysis 26 , quantitative PCR and in situ hybridization. Morpholino knockdown of prostaglandin pathway components 6, 8, 27 , and subsequent rescue by dmPGE2, was used to confirm the specificity of the results of the chemical treatments. Functional inhibition of prostaglandin synthesis was measured by mass spectroscopy for chemical and morpholino experiments. A flow-cytometry-based irradiation recovery assay was used to assess the impact of PGE2-mediated signalling on adult kidney marrow 28 . The effect of dmPGE2 and indomethacin on haematopoietic colony forming potential of embryonic stem cells was analysed by standard OP9 and methylcellulose colony forming assays 29, 30 . CFU-S assays and limiting dilution competitive transplantation assays were used to test the effects of ex vivo dmPGE2 treatment or COX inhibition on haematopoietic stem and progenitor populations. Bone marrow ablation 13 by 5-FU was used to test the in vivo effect of dmPGE2 or COX inhibitor treatment on haematopoietic recovery in mammals. 6 cells) on CFU-S8 and CFU-S12 (60,000 cells per recipient; CFU-S12: two-tailed t-test, control (mean/s.d./n) 5 5.78/2.73/9, dmPGE2 5 15.22/2.39/9, P , 0.0001). c, Effect on CFU-S12 following ex vivo treatment with indomethacin (1 mM per 10 6 cells) (100,000 cells/recipient; two-tailed t-test, control (mean/s.d./ n) 5 8.8/2.10/10, indomethacin 5 2.5/1.43/10, P 5 0.0001). d, CFU-S12 evaluation after treatment of cKit 
